These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38834219)

  • 1. Steroids Used to Treat Acne Vulgaris: A Review of Efficacy, Safety, and Clinical Considerations.
    Cantrell W; Easley L; Squittieri K
    J Drugs Dermatol; 2024 Jun; 23(6):404-409. PubMed ID: 38834219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated Short-Term and Long-Term Efficacy of Topical Clascoterone Cream 1% in Patients Aged 12 Years or Older With Acne Vulgaris.
    Eichenfield LF; Gold LS; Han J; Hebert AA; Mazzetti A; Moro L; Squittieri N; Thiboutot D
    J Drugs Dermatol; 2024 Jan; 23(1):1278-1283. PubMed ID: 38206145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypothalamic-Pituitary-Adrenal Axis Response in Patients With Acne Vulgaris Treated With Clascoterone.
    Bhatia N; Eichenfield LF; Mazzetti A; Moro L; Squittieri N; Hebert AA
    J Drugs Dermatol; 2024 Jun; 23(6):433-437. PubMed ID: 38834220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of Acne Vulgaris: A Review.
    Eichenfield DZ; Sprague J; Eichenfield LF
    JAMA; 2021 Nov; 326(20):2055-2067. PubMed ID: 34812859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Phase 2b, Randomized, Double-Blind Vehicle Controlled, Dose Escalation Study Evaluating Clascoterone 0.1%, 0.5%, and 1% Topical Cream in Subjects With Facial Acne.
    Mazzetti A; Moro L; Gerloni M; Cartwright M
    J Drugs Dermatol; 2019 Jun; 18(6):570. PubMed ID: 31251550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of hormonal agents in the treatment of acne.
    Hassoun LA; Chahal DS; Sivamani RK; Larsen LN
    Semin Cutan Med Surg; 2016 Jun; 35(2):68-73. PubMed ID: 27416311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic Profile, Safety, and Tolerability of Clascoterone (Cortexolone 17-alpha propionate, CB-03-01) Topical Cream, 1% in Subjects With Acne Vulgaris: An Open-Label Phase 2a Study.
    Mazzetti A; Moro L; Gerloni M; Cartwright M
    J Drugs Dermatol; 2019 Jun; 18(6):563. PubMed ID: 31251549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical Clascoterone: The First Novel Agent for Acne Vulgaris in 40 Years.
    Piszczatoski CR; Powell J
    Clin Ther; 2021 Oct; 43(10):1638-1644. PubMed ID: 34607697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Game Changer in Acne Treatment.
    Kircik LH
    J Drugs Dermatol; 2020 Mar; 19(3):28. PubMed ID: 32550698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unmet Needs in the Management of Acne Vulgaris: A Consensus Statement.
    Baldwin H; Farberg A; Frey C; Hartman C; Lain E; Meltzer R; Draelos Z
    J Drugs Dermatol; 2023 Jun; 22(6):582-587. PubMed ID: 37276154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgens and acne: perspectives on clascoterone, the first topical androgen receptor antagonist.
    Kircik LH
    Expert Opin Pharmacother; 2021 Sep; 22(13):1801-1806. PubMed ID: 33906537
    [No Abstract]   [Full Text] [Related]  

  • 12. Topical Clascoterone for Acne Vulgaris.
    Burma NE; Woo TE; Parsons L
    Skin Therapy Lett; 2022 Jan; 27(1):1-3. PubMed ID: 35081302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clascoterone: A Novel Topical Androgen Receptor Inhibitor for the Treatment of Acne.
    Kalabalik-Hoganson J; Frey KM; Ozdener-Poyraz AE; Slugocki M
    Ann Pharmacother; 2021 Oct; 55(10):1290-1296. PubMed ID: 33533262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic considerations for severe nodular acne.
    Newman MD; Bowe WP; Heughebaert C; Shalita AR
    Am J Clin Dermatol; 2011 Feb; 12(1):7-14. PubMed ID: 21062102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemical pharmacotherapy options for managing adult acne.
    Vera N; Patel N; Cardwell LA; Saleem M; Feldman SR
    Expert Opin Pharmacother; 2017 Feb; 18(3):263-273. PubMed ID: 28081648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Safe Management of Acne Vulgaris in Lupus Erythematosus: A Systematic Review with Evidence-Based Treatment Recommendations.
    Forouzandeh M; Maderal AD
    Am J Clin Dermatol; 2020 Feb; 21(1):13-20. PubMed ID: 31494859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clascoterone: a new topical anti-androgen for acne management.
    Santhosh P; George M
    Int J Dermatol; 2021 Dec; 60(12):1561-1565. PubMed ID: 34242398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adult Female Acne: Managing the Hormones.
    Lipson J
    Skin Therapy Lett; 2024 Jul; 29(4):5-7. PubMed ID: 38963912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Individual Article: Clascoterone Cream 1%: Mechanism of Action, Efficacy, and Safety of a Novel, First-in-Class Topical Antiandrogen Therapy for Acne.
    Peterson H; Kircik L; Armstrong AW
    J Drugs Dermatol; 2023 Jun; 22(6):SF350992s7-SF350992s14. PubMed ID: 37276168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clascoterone for treatment of acne.
    Manjaly C; Martinez J; Barbieri J; Mostaghimi A
    Drugs Today (Barc); 2023 Feb; 59(2):71-81. PubMed ID: 36811407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.